eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » GSK - Comment

GSK - Comment

Document ID: FDA-2008-D-0406-0004
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: August 29 2008, at 07:04 PM Eastern Daylight Time
Date Posted: August 31 2008, at 12:00 AM Eastern Standard Time
Comment Start Date: July 29 2008, at 12:00 AM Eastern Standard Time
Comment Due Date: September 29 2008, at 11:59 PM Eastern Standard Time
Tracking Number: 806e6d32
View Document:  View as format xml

View Comment

On line 18 can you include contract research organizations as well. In the case of when the Investigator is not a licesned PI and a sub PI is needed, does that Sub PI sign the 1572 as well. His/her name will be in the sub PI section. Can you please clarify

Related Comments

    View All
Total: 34
United BioSource Corporation - Comment
Public Submission    Posted: 08/14/2008     ID: FDA-2008-D-0406-0003

Sep 29,2008 11:59 PM ET
GSK - Comment
Public Submission    Posted: 08/31/2008     ID: FDA-2008-D-0406-0004

Sep 29,2008 11:59 PM ET
Rachel Suarez - Comment
Public Submission    Posted: 09/04/2008     ID: FDA-2008-D-0406-0005

Sep 29,2008 11:59 PM ET
Charles P. Andrews, MD CPI - Comment
Public Submission    Posted: 09/10/2008     ID: FDA-2008-D-0406-0006

Sep 29,2008 11:59 PM ET
Anonymous - Comment
Public Submission    Posted: 09/10/2008     ID: FDA-2008-D-0406-0007

Sep 29,2008 11:59 PM ET